citalopram

1
Reactions 1313 - 7 Aug 2010 S Citalopram Serotonin syndrome in an elderly patient: case report A 74-year-old woman with Alzheimer’s disease and behavioural problems developed serotonin syndrome during treatment with citalopram for depression. The woman had been maintained on citalopram 40 mg/day for 1 year [route of administration not stated], and had begun risperidone one day before admission for behavioural symptoms. She had recently developed diarrhoea. On admission she was confused, oriented only to person, with fluent but content-poor speech. Her dosage of risperidone was increased and she was treated with prochlorperazine for nausea and vomiting on day 3. She subsequently developed worsening tremor in her limbs, present with action or at rest, and a worsening shuffling gait with marked instability. Neurological examination 6 days after symptom onset revealed diffuse myoclonus involving all four limbs, and intermittent myoclonus of her face, mild- to-moderate non-spastic limb rigidity, generalised hyperreflexia and marked unsteadiness. She was oriented only to person. Her unsteadiness worsened such that she could no longer walk. Laboratory investigations revealed acute renal failure and mildly abnormal liver function 11 days after admission. The following day she also developed fever and diaphoresis. Serotonergic toxicity due to poor renal function was suspected. Intravenous volume replacement was commenced and citalopram was discontinued; she had received citalopram for 10 days since admission. The woman’s BUN and creatinine levels returned to baseline and after several days, her symptoms resolved completely. Her liver enzymes had normalised 3 weeks later. Author comment: "Based on the Naranjo scale, this patient’s clinical manifestations were possibly due to an adverse drug reaction secondary to citalopram." Yee AH, et al. A perfect storm in the emergency department. Neurocritical Care 12: 258-60, No. 2, Apr 2010 - USA 803029535 1 Reactions 7 Aug 2010 No. 1313 0114-9954/10/1313-0001/$14.95 © 2010 Adis Data Information BV. All rights reserved

Upload: duongminh

Post on 16-Mar-2017

217 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Citalopram

Reactions 1313 - 7 Aug 2010

SCitalopram

Serotonin syndrome in an elderly patient: casereport

A 74-year-old woman with Alzheimer’s disease andbehavioural problems developed serotonin syndromeduring treatment with citalopram for depression.

The woman had been maintained on citalopram40 mg/day for 1 year [route of administration not stated],and had begun risperidone one day before admission forbehavioural symptoms. She had recently developeddiarrhoea. On admission she was confused, oriented onlyto person, with fluent but content-poor speech. Her dosageof risperidone was increased and she was treated withprochlorperazine for nausea and vomiting on day 3. Shesubsequently developed worsening tremor in her limbs,present with action or at rest, and a worsening shuffling gaitwith marked instability. Neurological examination 6 daysafter symptom onset revealed diffuse myoclonus involvingall four limbs, and intermittent myoclonus of her face, mild-to-moderate non-spastic limb rigidity, generalisedhyperreflexia and marked unsteadiness. She was orientedonly to person. Her unsteadiness worsened such that shecould no longer walk. Laboratory investigations revealedacute renal failure and mildly abnormal liver function11 days after admission. The following day she alsodeveloped fever and diaphoresis. Serotonergic toxicity dueto poor renal function was suspected.

Intravenous volume replacement was commenced andcitalopram was discontinued; she had received citalopramfor 10 days since admission. The woman’s BUN andcreatinine levels returned to baseline and after several days,her symptoms resolved completely. Her liver enzymes hadnormalised 3 weeks later.

Author comment: "Based on the Naranjo scale, thispatient’s clinical manifestations were possibly due to anadverse drug reaction secondary to citalopram."Yee AH, et al. A perfect storm in the emergency department. Neurocritical Care12: 258-60, No. 2, Apr 2010 - USA 803029535

1

Reactions 7 Aug 2010 No. 13130114-9954/10/1313-0001/$14.95 © 2010 Adis Data Information BV. All rights reserved